SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 2nd, 2023 • Amicus Therapeutics, Inc. • Pharmaceutical preparations • Delaware
THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”) is made effective as of October 2, 2023 (the “SPA Effective Date”), by and among Amicus Therapeutics, Inc., a Delaware corporation with its principal place of business at 3675 Market Street, Philadelphia, PA 19104 (“Amicus”), and each Purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
LOAN AGREEMENT Dated as of October 2, 2023 between AMICUS THERAPEUTICS, INC., (as Borrower), Certain Subsidiaries of Borrower from time to time party hereto, (as other Credit Parties), WILMINGTON TRUST, NATIONAL ASSOCIATION, (as Agent) BLACKSTONE...Loan Agreement • October 2nd, 2023 • Amicus Therapeutics, Inc. • Pharmaceutical preparations • New York
THIS LOAN AGREEMENT (this “Agreement”), dated as of October 2, 2023 (the “Closing Date”), is by and among AMICUS THERAPEUTICS, INC., a Delaware corporation (as “Borrower”), each other Person from time to time party hereto that is designated as a “Credit Party” (as defined below), WILMINGTON TRUST, NATIONAL ASSOCIATION (as “Agent”), Blackstone Alternative Credit Advisors LP and Blackstone Life Sciences Advisors L.L.C., (collectively, as the “Blackstone Representative”) and each lender from time to time party hereto (each individually a “Lender” and collectively, the “Lenders”).
